Sprint Bioscience AB (publ) (SPRINT.ST)

Sweden · Healthcare · SEK

Key financials

ROE: -
ROA: -
Gross Margin: -
Net Margin: -
Total Assets: -
Net Income: -
Valuation: -
Stock Price: SEK 1.47; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030	Trend
Stock Price	SEK 1.47	SEK 1.47	SEK 1.47	SEK 1.47	SEK 1.47	SEK 1.47
Sector average	SEK 57.22	SEK 48.04	SEK 48.69	SEK 50.45	SEK 52.13	SEK 53.41

Amounts in SEK; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Sprint Bioscience AB (publ)? It covers the balance sheet, income statement and Equlion model projections.